COVID-19 IN SWITZERLAND. Week to 22.05.2021—down

May 26: next easing decision

Per 100K pop, total & last 2 weeks
● cases—7951 & 187 (dn)
● in hospital—329 & 5 (dn)
● deaths—118 & 0.7 (dn)

R(e): up—0.90
Vaccinations: 4.0m (1.4m 2nd doses)

FOPH covid19.admin.ch/en/overview?ov…

1/11 Screenshot of box on lab-confirmed cases with data and chartScreenshot of box on lab-confirmed hospitalisations with datScreenshot of box on lab-confirmed deaths with data and charScreenshot of box on reproductive number Re (lag in calculat
AND FOR THE PAST FORTNIGHT, R(e) since Sep28

covid19.admin.ch/en/overview

2/11 Screenshot of box on lab-confirmed cases (past fortnight) wiScreenshot of box on lab-confirmed hospitalisations (past foScreenshot of box on lab-confirmed deaths (past fortnight) wScreenshot of Reproductive number since 28.09.2020
VIRUS VARIANTS detected

UK variant dominant. Indian starting to show

Public Health Office: covid19.admin.ch/en/epidemiolog…
Science Task Force: sciencetaskforce.ch/en/nextstrain-…

3/11 Screenshot of list of variants and numbers identified (PubliScreenshot of graph of estimated proportion of relevant variScreenshot: Task Force graph of estimated percentage of B.1.Screenshot: Task Force graph of estimated percentage of P.1
BY CANTON: LAB-CONFIRMED CASES IN the past fortnight per 100K population—down. Worst still in Uri, also Appenzell Innerrhoden. Dark end of scale down from 529 to 446.

More: covid19.admin.ch/en/epidemiolog…

4/11 Screenshot of map showing different rates by canton: lab-con
BY CANTON: LAB-CONFIRMED HOSPITALISATION in the past fortnight per 100K population—Improving, down from 6.04 to 4.82. Worse in and around Uri, so dark end of scale up from 27 to 30

More: covid19.admin.ch/en/epidemiolog…

5/11 Screenshot of map showing different rates by canton: lab-con
BY CANTON: DEATHS (which lag case numbers)—down from 0.9 to 0.7. Still worst in and around Uri. Elsewhere better. Dark end of scale stays at 5.45.

More: covid19.admin.ch/en/epidemiolog…

6/11 Screenshot of map showing different rates by canton: lab-con
INTENSIVE CARE CAPACITY AND OCCUPANCY: all patients and COVID-19

Over 150 hospitals/clinics (Glarus, Appenzell Innerrhoden have no IC units)

All patients: Slightly worse, eg in West

COVID-19: improving, except Schaffhausen

More: covid19.admin.ch/en/hosp-capaci…

7/11 Map of occupancy rates: all patientsMap of occupancy rates: COVID-19 patientsChart of COVID-19 and non-COVID-19 occupancy since March 202
R(e) ESTIMATES: national over time, cantons latest.

Up slightly. Better in the Alpine cantons <0.8, >1 in Fribourg, Jura, Obwalden and NE

Estimate: 0.90 nationally (from 0.87)

More: covid19.admin.ch/en/repro/val

Note: Swiss schools have stayed open during lockdown

8/11 Chart of reproductive number over timeMap of reproductive number by canton
VACCINATIONS (1) VACCINES & DEMOGRAPHY

Pfizer/BioNTech & Moderna roughly equal

Ordered: 36m doses: Pfizer/BioNTech, Moderna, AstraZeneca, Curevac and Novavax (pop 8.6m)

Approved: Pfizer/BioNTech, Moderna, J&J (not ordered)

covid19.admin.ch/en/epidemiolog…
covid19.admin.ch/en/epidemiolog…

9/11 Screenshot of graph of administered vaccine doses, Pfizer/BiScreenshot of graph of fully vaccinated people, Pfizer/BioNTScreenshot of graphic of demography of administered vaccine Screenshot of graphic of demography of fully vaccinated peop
VACCINATIONS (2) OVERALL

Clearly accelerating
Delivered: 4.7m=54% (from 3.9m/45%)
Administered: 3.9m=46% (from 3.5m/41%) (2 doses for whole population = 200%)
Fully (2 doses): 1.4m=14.3% (from 1.2m/13.7%)

covid19.admin.ch/en/epidemiolog…
covid19.admin.ch/en/epidemiolog…

10/11 Screenshot: Chart of development over time of delivered and Screenshot: map of administered vaccine doses, per 100, by cScreenshot: Chart of development over time of vaccinated peoScreenshot: map of fully vaccinated people per 100, by canto
LATEST: Decision May 26 on next phase, includes restaurants open indoors

Some cantons now vaccinating all adults (some over-16s)

A forgery-proof Covid-19 certificate available by the end of June

CURRENT SITUATION: swissinfo.ch/eng/covid-19_c… Graphic of measures from April 19

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Peter Ungphakorn

Peter Ungphakorn Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @CoppetainPU

22 May
(Nervously starts typing what’s going to be an unpopular thread)

India, South Africa and allies have now circulated a new draft for the WTO intellectual property waiver for COVID-19.

KEI Online has it. Not yet in WTO DocsOnline—Monday?

1/19 #TRIPSwaiver keionline.org/wp-content/upl…
“It’s been a long time comin’
It’s goin’ to be a long time gone

“And it appears to be a long
Appears to be a long
Appears to be a long time
Yes, a long, long, long, long time before the dawn”

So long to prepare, so little changed, lots to do

2/19
It’s hard to believe this draft was intended to enable quick agreement to waive obligations under the WTO intellectual property (“TRIPS”) agreement

It’s extreme—a blank cheque with some minor tweaks—not a draft than can be quickly settled.

3/19 keionline.org/wp-content/upl…
Read 19 tweets
19 May
UK hit trade topic today: #TariffQuotas/#TariffRateQuotas

What are they?

One way to compromise between high protective tariffs and market access
⬇️
Low or zero duty for limited quantities (quotas). Beyond that high tariffs kick in—not “phased in” @nicholaswatt @BBCr4today

1/6
That way the two tariff levels allow some market access but keep it limited so some protection remains for local producers

It’s not the only way to compromise. Another: set a medium-level tariff for all imports of that product. But quantities would depend on supply & demand

2/6
Advantage of a tariff quota: the limit of low/zero duty imports is known. With a medium tariff it is not known.

Disadvantages: complexity in the way the govt hands out the quota among importers, and “quota rent”—benefits, sometimes huge, to those with a share of the quota

3/6
Read 8 tweets
17 May
TRADE GEEK CORNER

Brazil has 2 new papers on domestic support in the WTO agriculture talks, analysis rather than proposals.

1. The exemption for developing countries allowing unlimited investment and input support even if trade-distorting (Art6.2)

1/4

docs.wto.org/dol2fe/Pages/S…
Among the paper's observations:

—only some developing countries use this exception (Art6.2), some a lot (eg India, Indonesia, not named in the paper)

—some exception continue to be needed to help poor farmers but not as an excuse to support "highly exported products"

2/4
2. Blue Box (Art6.5) ie trade-distorting support but with production limits, so currently allowed in unlimited amounts

Brazil says Blue Box should be negotiated too

The paper says only 5 countries are using this type of support; "A, B, C, D, and E"

3/4

docs.wto.org/dol2fe/Pages/S…
Read 4 tweets
15 May
COVID-19 IN SWITZERLAND. Week to 15.05.2021—down

May 26: decision, more easing end-May?

Per 100K pop, total & last 2 wks
● cases—7860 & 217 (⬇️)
● in hospital—326 & 6 (⬇️)
● deaths—118 & 0.9 (⬇️)

R(e): up—0.87
Vaccs: 3.5m (1.2m 2nd doses)

FOPH covid19.admin.ch/en/overview?ov…

1/11 Screenshot of box on lab-co...Screenshot of box on lab-co...Screenshot of box on lab-co...Screenshot of box on reprod...
AND FOR THE PAST FORTNIGHT, R(e) since Sep28

covid19.admin.ch/en/overview

2/11 Screenshot of box on lab-co...Screenshot of box on lab-co...Screenshot of box on lab-co...Screenshot of Reproductive ...
VIRUS VARIANTS detected

UK variant estimated 95%

Public Health Office: covid19.admin.ch/en/epidemiolog…
Science Task Force: sciencetaskforce.ch/en/nextstrain-…

3/11 Screenshot of list of varia...Screenshot of graph of esti...Screenshot: Task Force grap...
Read 11 tweets
12 May
One to watch with (some) implications for the controversial WTO #Covid19Waiver on intellectual property protection.

Bolivia wants to import a generic version of the J&J COVID-19 #vaccine made under “compulsory” licence By @BiolysePharma in Canada

1/17

globalnews.ca/news/7851500/b…
This may test the claim by #Covid19Waiver supporters that this route is too cumbersome

Under WTO rules, @BiolysePharma first had to try to get a voluntary licence from J&J to produce the vaccine. It tried in March and was rejected.

2/17

healthpolicy-watch.news/company-pushes…
Although the objective is to get a cheaper generic version of the vaccine to a developing country—Bolivia—a lot the focus will be on Canada.

Ottawa has to issue a compulsory licence to export, which has special rules. So far, no news on that

3/17

globalnews.ca/news/7851500/b… Image
Read 18 tweets
8 May
COVID-19 IN SWITZERLAND. Week to 08.05.2021—slight improvement

Last easing Apr 19

Per 100K pop, total & last 2 wks
● cases—7757 & 267 (⬆️)
● in hospital—321 & 8 (⬇️)
● deaths—117 & 1.2 (⬆️)

R(e): down—0.85
Vaccinations: 3m (1m 2nd doses)

FOPH covid19.admin.ch/en/overview?ov…

1/10 Screenshot of box on lab-co...Screenshot of box on lab-co...Screenshot of box on lab-co...Screenshot of box on reprod...
AND FOR THE PAST FORTNIGHT, R(e) since Sep28

covid19.admin.ch/en/overview

Pfizer/BioNTech, Moderna mRNA vaccinations ongoing. J&J approved, not ordered. Supply picking up. Not yet approved: AstraZeneca, Curevac and Novavax. Switzerland has ordered over 30m doses for 8m people

2/10 Screenshot of box on lab-co...Screenshot of box on lab-co...Screenshot of box on lab-co...Screenshot of Reproductive ...
VIRUS VARIANTS detected

UK variant dominant

Public Health Office: covid19.admin.ch/en/epidemiolog…
Science Task Force: sciencetaskforce.ch/en/nextstrain-…

3/10 Screenshot of list of varia...Screenshot of graph of esti...
Read 10 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(